Supplemental Financial Data (Tables)

12 Months Ended

Dec. 31, 2023

Supplemental Financial Data [Abstract]

Inventories

Our inventory consisted of the following (in thousands):

	December 31,
	2023		2022
Raw materials:
Raw materials- clinical	$	20,985	$	17,061
Raw materials- commercial		1,809		2,699
Total raw materials		22,794		19,760
Work in process		5,477		2,109
Finished goods		154		164
Total inventory	$	28,425	$	22,033

Property, Plant and Equipment

Our property, plant and equipment consisted of the following (in thousands):

	December 31,
	2023			2022
Computer software, laboratory, manufacturing and other equipment	$	79,885		$	74,351
Building, building improvements and building systems		41,228			41,158
Leasehold improvements		28,276			28,357
Furniture and fixtures		9,844			9,575
		159,233			153,441
Less: Accumulated depreciation		(96,759	)		(87,716	)
		62,474			65,725
Land		8,569			8,569
Total	$	71,043		$	74,294

Accrued Liabilities

Our accrued liabilities consisted of the following (in thousands):

	December 31,
	2023		2022
Clinical expenses	$	105,967	$	116,460
In-licensing expenses		7,454		7,945
Commercial expenses		4,875		3,498
Other miscellaneous expenses		29,598		12,198
Total accrued liabilities	$	147,894	$	140,101